Injectable drug delivery is defined as administration of a drug or drugs directly into patients blood circulationthrough a delivery device. It is considered as the most common and effective route of administration of most therapeutic agents to achieve the desired quick response. The injectable route of drug administration is expected to continue to be an important delivery system. This has been attributed to reasons that injectable drug delivery system allows administration of drugs with poor oral bioavailability, delivery of the drug at the site of action, targeted drug delivery system. Reduction in the number of injection is achieved by various technologies such as controlled release, targeted delivery and needle free delivery thus overcoming the problems associated with conventional injectable drug delivery. This has also helped in improving quality of therapy. Injectable drug delivery has also proved beneficial in many cases such as unconsciousness, emergency conditions and nausea, due to rapid onset of action. The basic requirement for injectable drug delivery is that it should be pyrogen free, sterile and isotonic.
Scope of the Report:
This report focuses on the Injectable Drug Delivery in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
- Becton, Dickinson and Company, Baxter International, Gerresheimer, Pfizer, Schott, Sandoz, Teva Pharmaceutical Industries, Eli Lilly and Company, Antares Pharma, Eli Lilly & Company, Hospira, Novo Nordik, Sanofi, Terumo Corporation, Unilife Corporation, Zogenix, Scandinavian Health,
Market Segment by Regions, regional analysis covers
- North America (USA, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America, Middle East and Africa
Market Segment by Type, covers
- Immunosuppressive Agents
- Antihypertensive Agents
Market Segment by Applications, can be divided into
- Autoimmune Diseases
- Hormonal Disorders
- Infectious Diseases
- Pain Management
There are 13 Chapters to deeply display the global Injectable Drug Delivery market.
Chapter 1, to describe Injectable Drug Delivery Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Injectable Drug Delivery, with sales, revenue, and price of Injectable Drug Delivery, in 2015 and 2016;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2015 and 2016;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Injectable Drug Delivery, for each region, from 2011 to 2016;
Chapter 5, 6, 7 and 8, to analyze the key regions, with sales, revenue and market share by key countries in these regions;
Chapter 9 and 10, to show the market by type and application, with sales market share and growth rate by type, application, from 2011 to 2016;
Chapter 11, Injectable Drug Delivery market forecast, by regions, type and application, with sales and revenue, from 2016 to 2021;
Chapter 12 and 13, to describe Injectable Drug Delivery sales channel, distributors, traders, dealers, Appendix and data source.